Programs

Cancer
Autoimmune
Disease Target To Be Defined
Antibody
Antibody
Small Molecule
Small Molecule
Discovery
Preclinical
IND Enabling
Clinical
GIM-122 (First-in-class)
Dual-functioning
GIM-531 (First-in-class)
Treg Inhibitor
GIM-407 (First-in-class)
Treg Activator
GIM-616 (First-in-class)
Undisclosed
GIM-710 (First-in-class)
Undisclosed
GIM-0915 (First-in-class)
Undisclosed
GIM-0621 (First-in-class)
Undisclosed
GIM-0228 (First-in-class)
Undisclosed
GIM-1213s
Several Targets